Mice treated with the gene therapy remained cancer-free for at least 100 days and resisted cancer resurgence in a lab test.

Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing enabling technology, and Charles River Laboratories (Charles River), a global industry-leading drug discovery, preclinical ...

But all is not well in the world of sickle cell gene therapy. Image Kendric underwent four days of intense chemotherapy to clear his bone marrow, which makes way for his treated cells to ...

Rocket Pharmaceuticals announced enrollment completion for phase 2 study using its gene therapy RP-A501 for treatment of male ...

Picking a growth stock ... therapy treats sickle cell disease and transfusion-dependent beta thalassemia. Both are rare, ...

Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $29.9 billion by 2032, ...

s TRACER™ (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) capsid discovery platform is a broadly applicable, RNA-based screening platform that enables rapid discovery of novel AAV ...

The software features an easy-to-use interface to speed up DTF image preparation at the production stage ... connector that fits directly into the freeze cassettes used in cell and gene therapy (CGT) ...

The Cell & Gene Therapy manufacturing Services market is driven by increasing investments in advanced therapies, rising ...

It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.

Advancements in cell and gene therapy have been driven by improved insights into the human immune system and a better ...